• Green River Gold (CCR) has updated progress on the 2022 exploration program at its Quesnel Nickel / Magnesium / Talc Project
  • President and CEO Perry Little sat down with Daniella Atkinson to discuss the program
  • The highest nickel grade encountered so far in Zone 2 is 0.245 per cent over 3 metres in hole FCD-22-03
  • All five of the new holes in Zone 2 encountered nickel and chromium mineralization from surface as have all the holes drilled in Zone 1 to date
  • Green River Gold Corp. (CCR) opened trading at C$0.075

Green River Gold (CCR) has updated progress on the 2022 exploration program at its Quesnel Nickel / Magnesium / Talc Project.

President and CEO Perry Little sat down with Daniella Atkinson to discuss the program.

“Our geologists felt that higher nickel grades were likely to be found as we moved away from the talc and so far, that theory seems to be holding up. We look forward to seeing assay results for some of the new holes to see if they contain magnesium as well as nickel and chromium. This new outcropping, Zone 2, is 8 kilometres from Zone 1, but on the same 14-kilometre-long magnetic anomaly, giving us hope that the entire magnetic anomaly may contain similar mineralization.”

Shallow drilling continues as the company expands the area of known mineralization and gathers information to help choose locations for deeper drilling.

Source: Green River Gold Corp.

Green River Gold Corp. is a Canadian mineral exploration company focused on its wholly-owned high-grade Fontaine Gold Project, Quesnel Nickel/Magnesium/Talc Project, and Kymar Silver Project, located in renowned mining districts in British Columbia.

Green River Gold Corp. (CCR) opened trading at C$0.075.


More From The Market Online
The Market Online Video

Exploration company provides project portfolio update

Banyan Gold Corp. (TSXV:BYN) is focused on exploration and advancing and de-risking its AurMac Gold Project in the Yukon.
stock market down

@ the Bell: Industrials weakness snaps TSX win streak

Industrials led decliners, followed by financials, to snap the TSX’s five-day win streak while energy, utilities and mining provided gains.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.